Source: centralcharts

Press Release: JAMA Network : JAMA Neurology Publishes Positive Pivotal Clinical Trial with Vamorolone in Duchenne Muscular Dystrophy

Results from the VISION-DMD study show ing efficacy and safety of v amorolone compared to placebo and to standard of care, prednisone, has been published in

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
250-500
Atul Kumar Tandon's photo - General Manager of JAMA Network

General Manager

Atul Kumar Tandon

CEO Approval Rating

- -/100

Read more